Knockdown of MYB sensitized acute lymphoblastic leukemia (ALL) cells to doxorubicin and 6-mercaptopurine by downregulating anti-apoptotic BCL2 [25]. This evidence concerns the gene MYB and acute lymphoblastic leukemia.